Find a Trial
Trial Summary
| Protocol No. | PHO-COG-CROOP-ADVL1822 | ||
|---|---|---|---|
| Status | SUSPENDED | ||
| Principal Investigator | Batra, Sandeep | ||
| Scope | National | ||
| Phase | Phase I/II | ||
| Age Group | Adults and Children | ||
| Title | A PHASE 1/2, MULTI-CENTER, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF QUIZARTINIB ADMINISTERED IN COMBINATION WITH RE-INDUCTION CHEMOTHERAPY, AND AS A SINGLE-AGENT MAINTENANCE THERAPY, IN PEDIATRIC RELAPSED/REFRACTORY AML SUBJECTS AGED 1 MONTH TO < 18 YEARS (AND YOUNG ADULTS AGED UP TO 21 YEARS) WITH FLT3-ITD MUTATIONS | ||
| Applicable Disease Sites | Myeloid and Monocytic Leukemia | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||